cancer prevention intervention
cancer prevention intervention is a medical procedure with 10 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
9
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
10.0%
1 of 10 finished
90.0%
9 ended early
0
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix
Antineoplaston Therapy in Treating Women With Advanced Breast Cancer
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
Antineoplaston Therapy in Treating Patients With Colon Cancer
Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast Cancer
Clinical Trials (10)
S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix
Antineoplaston Therapy in Treating Women With Advanced Breast Cancer
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
Antineoplaston Therapy in Treating Patients With Colon Cancer
Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast Cancer
Antineoplaston Therapy in Treating Patients With Primary Central Nervous System Lymphoma
Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy
Antineoplaston Therapy in Treating Patients With Mantle Cell Lymphoma
Registration and Informed Consent Study for the Childhood Cancer Research Network
Celecoxib in Preventing Skin Cancer
All 10 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 10